This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Privateequity funds have become major players in the professional health care delivery sector in recent years due to acquisitions of professional practices, including physician practices, senior living facilities and the like. Acquisitions of professional practices by privateequity funds involve myriad.
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
We are seeing an increasing amount of privateequity entering the veterinary space, both at the clinic level and the pet product level. Privateequity is already investing heavily in the pet industry, and it is expected to continue to grow. making it highly competitive to get into.
The 6th annual Midwest M&A/PrivateEquity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.
In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. The privateequity firms involved had to navigate a storm of stakeholder concerns. What is a Shareholder?
Excolere Equity Partners is a leading middle market privateequity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector. ISP Schools is a portfolio company of OMERS PrivateEquity.
Serving a variety of end markets, including aerospace & defense, electronics and industrials, National offers especially deep experience in the medical end market across various implantable devices, including pacemakers, neuromodulation devices, defibrillators, batteries and capacitors. National”).
Targeting sectors with rigorous technical specifications, regulatory compliance standards, and exacting quality requirements, MSK serves customers primarily in the medical, aerospace & defense and telecommunications end markets.
Washington, DC, (September 27, 2024) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Dulles Eye Associates has joined ReFocus Eye Health as a supported practice.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. FOCUS managing directors Eric Yetter and Andy Snyder advised Mid-Michigan ENT in this partnership.
They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. They are among the most active advisors to medical professionals in transactions with privateequity-backed organizations. “We who serves as Michigan ENT’s managing partner.
Tyton Partners 2024 Transactions Corporate Training and Continuing Education Transaction Spotlight The corporate training and continuing education market experienced remarkable growth in transaction volume over the past year, outpacing other segments within the global knowledge industry.
CORE, a privateequity firm focused on manufacturing, industrial technology, and industrial services, previously acquired GEM, a provider of precision deep-drawn metal components and mechanical assemblies, in February 2023. PMP”), a provider of specialty stamping and machining services. FOCUS represented CORE in this transaction.
The brand operates 20 corporate stores and has a team of 30 people on the corporate side and another 60 retail employees. The brand also receives many medical referrals from podiatrists and other foot specialists. Foot Solutions was not always a thriving franchise.
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., based privateequity investor that specializes in acquiring software businesses in partnership with top mid-career executives. a leading health care software company, in its acquisition by The Brydon Group.
Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
It may come as no surprise that the public sector (with the exception of the military) typically lags behind corporate America regarding technology. Digging deeper reveals some underlying trends that SaaS businesses and their potential buyers would do well to understand. Upgrades are overdue and imperative. The size and scope of the U.S.
Out of the Nordic countries, companies such as Novo Nordisk capitalized on massive revenue boosts from weight-loss medications (Wegovy and Ozempic) with multibillion-dollar acquisitions. As a result, we expect PE activity to be particularly robust throughout the year, driving cross-border dealmaking in the process.
Vice Chancellor Lasters opinion captioned In re Dura Medic Holdings, Inc. The case involved claims brought by a co-founder of Dura Medic, Inc. Dura Medic or Company) against affiliates of Comvest, a privateequity backer that acquired Dura Medic in 2018 through subsidiary affiliates.
Vice Chancellor Lasters opinion in In re Dura Medic Holdings, Inc. The case involved claims brought by a co-founder of Dura Medic, Inc. Dura Medic or Company) against affiliates of Comvest, a privateequity backer that acquired Dura Medic in 2018 through subsidiary affiliates.
PrivateEquity in Franchising – PE-backed franchises can be a red flag for some buyers, as corporate strategies may prioritize investor returns over franchisee success. Some are owned by privateequity firms, which can change the dynamics of the business, sometimes prioritizing investor returns over franchisee success.
McKessons acquisition of PRISM Vision Group is an important milestone for privateequitys investments in optometry practices. At the same time, there has always been uncertainty about the ultimate home for these assets, since privateequity does not keep its investments forever.
Privateequity investments in healthcare provider practices are getting more mature and changing the way buyers and sellers approach transactions. Deal activity has been high across dentistry, veterinary, and the physician specialties, with more than 100 privateequity backed platforms established and completing their own add-on deals.
For example, there are multi-billion-dollar biotech hedge funds with 10%, 20%, or even 30% of their total capital in single companies : 3) Public / Private Crossover Finally, many biotech hedge funds also have divisions that invest in private startups, similar to life sciences venture capital firms and healthcare growth equity firms.
Financial Buyers : Privateequity firms and investment groups interested in businesses with strong cash flow and growth potential. For example, in a healthcare M&A transaction, an advisor might vet a prospective buyer interested in acquiring a medical practice.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content